Surrey Heartlands

Joint Formulary & PAD

Domperidone - Nausea and vomiting (Parkinson's disease)

You are here : Home > Formulary Search > Domperidone - Nausea and vomiting (Parkinson's disease)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :

Documentation

Evidence Review
Domperidone treatment - Evidence Review - December 2019.pdf

PAD Profile

ChemicalSubstance :
Domperidone
Indication :
Nausea and vomiting (Parkinson's disease)
Group Name :
Keywords :
sickness, PD
Brand Names Include :
Motilium
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Domperidone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nausea and vomiting (Parkinson's disease).

  • No records returned.

Committee Recommendations (1)

04 Dec 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee recommends the off label use of domperidone for the treatment of nausea & vomiting  when used in Parkinson's Disease patients, as recommended within NICE Clinical Knowledge Summaries (CKS) https://cks.nice.org.uk/parkinsons-disease 

Treatment duration is restricted to a maximum of one week in all patients*.

Prescribers should ensure that the patient understands the risks and consents to using domperidone off-label noting the MHRA drug safety alert (updated December 2019)

Domperidone will be considered GREEN on the traffic light system for this indication.

*MHRA drug safety update (December 2019) https://www.gov.uk/drug-safety-update/domperidone-for-nausea-and-vomiting-lack-of-efficacy-in-children-reminder-of-contraindications-in-adults-and-adolescents